img

Global Oral Bordetella Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Bordetella Vaccine Market Insights, Forecast to 2034

Global Oral Bordetella Vaccine market is expected to reach to US$ 152 million in 2024, with a positive growth of %, compared with US$ 125 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Oral Bordetella Vaccine industry is evaluated to reach US$ 444.9 million in 2029. The CAGR will be 19.6% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Oral Bordetella Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Oral Bordetella Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Boehringer Ingelheim(Merial)
Merck Animal Health
Zoetis
Elanco
Segment by Type
Combination Vaccine
Only Bordetella Vaccine

Segment by Application


Puppies
Adult Dogs

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Oral Bordetella Vaccine plant distribution, commercial date of Oral Bordetella Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Oral Bordetella Vaccine introduction, etc. Oral Bordetella Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Oral Bordetella Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Oral Bordetella Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Oral Bordetella Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Combination Vaccine
1.2.3 Only Bordetella Vaccine
1.3 Market by Application
1.3.1 Global Oral Bordetella Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Puppies
1.3.3 Adult Dogs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oral Bordetella Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Oral Bordetella Vaccine Revenue by Region
2.2.1 Global Oral Bordetella Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Oral Bordetella Vaccine Revenue by Region (2018-2024)
2.2.3 Global Oral Bordetella Vaccine Revenue by Region (2024-2029)
2.2.4 Global Oral Bordetella Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Oral Bordetella Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Oral Bordetella Vaccine Sales by Region
2.4.1 Global Oral Bordetella Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Oral Bordetella Vaccine Sales by Region (2018-2024)
2.4.3 Global Oral Bordetella Vaccine Sales by Region (2024-2029)
2.4.4 Global Oral Bordetella Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Oral Bordetella Vaccine Sales by Manufacturers
3.1.1 Global Oral Bordetella Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Oral Bordetella Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Bordetella Vaccine in 2022
3.2 Global Oral Bordetella Vaccine Revenue by Manufacturers
3.2.1 Global Oral Bordetella Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Oral Bordetella Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Oral Bordetella Vaccine Revenue in 2022
3.3 Global Key Players of Oral Bordetella Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Oral Bordetella Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Oral Bordetella Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Oral Bordetella Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Oral Bordetella Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Oral Bordetella Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Bordetella Vaccine Sales by Type
4.1.1 Global Oral Bordetella Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Oral Bordetella Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Oral Bordetella Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Oral Bordetella Vaccine Revenue by Type
4.2.1 Global Oral Bordetella Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Oral Bordetella Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Oral Bordetella Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Oral Bordetella Vaccine Price by Type
4.3.1 Global Oral Bordetella Vaccine Price by Type (2018-2024)
4.3.2 Global Oral Bordetella Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Oral Bordetella Vaccine Sales by Application
5.1.1 Global Oral Bordetella Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Oral Bordetella Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Oral Bordetella Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Oral Bordetella Vaccine Revenue by Application
5.2.1 Global Oral Bordetella Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Oral Bordetella Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Oral Bordetella Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Oral Bordetella Vaccine Price by Application
5.3.1 Global Oral Bordetella Vaccine Price by Application (2018-2024)
5.3.2 Global Oral Bordetella Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Oral Bordetella Vaccine Market Size by Type
6.1.1 US & Canada Oral Bordetella Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Oral Bordetella Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Oral Bordetella Vaccine Market Size by Application
6.2.1 US & Canada Oral Bordetella Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Oral Bordetella Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Oral Bordetella Vaccine Market Size by Country
6.3.1 US & Canada Oral Bordetella Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Oral Bordetella Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Oral Bordetella Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Oral Bordetella Vaccine Market Size by Type
7.1.1 Europe Oral Bordetella Vaccine Sales by Type (2018-2029)
7.1.2 Europe Oral Bordetella Vaccine Revenue by Type (2018-2029)
7.2 Europe Oral Bordetella Vaccine Market Size by Application
7.2.1 Europe Oral Bordetella Vaccine Sales by Application (2018-2029)
7.2.2 Europe Oral Bordetella Vaccine Revenue by Application (2018-2029)
7.3 Europe Oral Bordetella Vaccine Market Size by Country
7.3.1 Europe Oral Bordetella Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Oral Bordetella Vaccine Sales by Country (2018-2029)
7.3.3 Europe Oral Bordetella Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Oral Bordetella Vaccine Market Size
8.1.1 China Oral Bordetella Vaccine Sales (2018-2029)
8.1.2 China Oral Bordetella Vaccine Revenue (2018-2029)
8.2 China Oral Bordetella Vaccine Market Size by Application
8.2.1 China Oral Bordetella Vaccine Sales by Application (2018-2029)
8.2.2 China Oral Bordetella Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Oral Bordetella Vaccine Market Size by Type
9.1.1 Asia Oral Bordetella Vaccine Sales by Type (2018-2029)
9.1.2 Asia Oral Bordetella Vaccine Revenue by Type (2018-2029)
9.2 Asia Oral Bordetella Vaccine Market Size by Application
9.2.1 Asia Oral Bordetella Vaccine Sales by Application (2018-2029)
9.2.2 Asia Oral Bordetella Vaccine Revenue by Application (2018-2029)
9.3 Asia Oral Bordetella Vaccine Sales by Region
9.3.1 Asia Oral Bordetella Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Oral Bordetella Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Oral Bordetella Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Oral Bordetella Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Oral Bordetella Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Oral Bordetella Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Oral Bordetella Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Oral Bordetella Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Oral Bordetella Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Boehringer Ingelheim(Merial)
11.1.1 Boehringer Ingelheim(Merial) Company Information
11.1.2 Boehringer Ingelheim(Merial) Overview
11.1.3 Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boehringer Ingelheim(Merial) Recent Developments
11.2 Merck Animal Health
11.2.1 Merck Animal Health Company Information
11.2.2 Merck Animal Health Overview
11.2.3 Merck Animal Health Oral Bordetella Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck Animal Health Oral Bordetella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Animal Health Recent Developments
11.3 Zoetis
11.3.1 Zoetis Company Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Oral Bordetella Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Zoetis Oral Bordetella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis Recent Developments
11.4 Elanco
11.4.1 Elanco Company Information
11.4.2 Elanco Overview
11.4.3 Elanco Oral Bordetella Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Elanco Oral Bordetella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Elanco Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Bordetella Vaccine Industry Chain Analysis
12.2 Oral Bordetella Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Bordetella Vaccine Production Mode & Process
12.4 Oral Bordetella Vaccine Sales and Marketing
12.4.1 Oral Bordetella Vaccine Sales Channels
12.4.2 Oral Bordetella Vaccine Distributors
12.5 Oral Bordetella Vaccine Customers
13 Market Dynamics
13.1 Oral Bordetella Vaccine Industry Trends
13.2 Oral Bordetella Vaccine Market Drivers
13.3 Oral Bordetella Vaccine Market Challenges
13.4 Oral Bordetella Vaccine Market Restraints
14 Key Findings in The Global Oral Bordetella Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Oral Bordetella Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Combination Vaccine
Table 3. Major Manufacturers of Only Bordetella Vaccine
Table 4. Global Oral Bordetella Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Oral Bordetella Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Oral Bordetella Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Oral Bordetella Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Oral Bordetella Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Oral Bordetella Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Oral Bordetella Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Oral Bordetella Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Oral Bordetella Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Oral Bordetella Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Oral Bordetella Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Oral Bordetella Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Oral Bordetella Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Oral Bordetella Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Oral Bordetella Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Oral Bordetella Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Oral Bordetella Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Oral Bordetella Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Oral Bordetella Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Bordetella Vaccine as of 2022)
Table 23. Global Key Manufacturers of Oral Bordetella Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Oral Bordetella Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Oral Bordetella Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oral Bordetella Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Oral Bordetella Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Oral Bordetella Vaccine Sales Share by Type (2018-2024)
Table 30. Global Oral Bordetella Vaccine Sales Share by Type (2024-2029)
Table 31. Global Oral Bordetella Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Oral Bordetella Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Oral Bordetella Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Oral Bordetella Vaccine Revenue Share by Type (2024-2029)
Table 35. Oral Bordetella Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Oral Bordetella Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Oral Bordetella Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Oral Bordetella Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Oral Bordetella Vaccine Sales Share by Application (2018-2024)
Table 40. Global Oral Bordetella Vaccine Sales Share by Application (2024-2029)
Table 41. Global Oral Bordetella Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Oral Bordetella Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Oral Bordetella Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Oral Bordetella Vaccine Revenue Share by Application (2024-2029)
Table 45. Oral Bordetella Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Oral Bordetella Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Oral Bordetella Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Oral Bordetella Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Oral Bordetella Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Oral Bordetella Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Oral Bordetella Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Oral Bordetella Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Oral Bordetella Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Oral Bordetella Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Oral Bordetella Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Oral Bordetella Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Oral Bordetella Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Oral Bordetella Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Oral Bordetella Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Oral Bordetella Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Oral Bordetella Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Oral Bordetella Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Oral Bordetella Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Oral Bordetella Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Oral Bordetella Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Oral Bordetella Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Oral Bordetella Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Oral Bordetella Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Oral Bordetella Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Oral Bordetella Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Oral Bordetella Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Oral Bordetella Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Oral Bordetella Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Oral Bordetella Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Oral Bordetella Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Oral Bordetella Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Oral Bordetella Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Oral Bordetella Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Oral Bordetella Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Oral Bordetella Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Oral Bordetella Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Oral Bordetella Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Oral Bordetella Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Oral Bordetella Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Oral Bordetella Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Oral Bordetella Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Oral Bordetella Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Oral Bordetella Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Oral Bordetella Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Oral Bordetella Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Oral Bordetella Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Oral Bordetella Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Oral Bordetella Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Oral Bordetella Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Oral Bordetella Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Oral Bordetella Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Oral Bordetella Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Oral Bordetella Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Oral Bordetella Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. Boehringer Ingelheim(Merial) Company Information
Table 108. Boehringer Ingelheim(Merial) Description and Major Businesses
Table 109. Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Boehringer Ingelheim(Merial) Recent Developments
Table 112. Merck Animal Health Company Information
Table 113. Merck Animal Health Description and Major Businesses
Table 114. Merck Animal Health Oral Bordetella Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Merck Animal Health Oral Bordetella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Animal Health Recent Developments
Table 117. Zoetis Company Information
Table 118. Zoetis Description and Major Businesses
Table 119. Zoetis Oral Bordetella Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Zoetis Oral Bordetella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Zoetis Recent Developments
Table 122. Elanco Company Information
Table 123. Elanco Description and Major Businesses
Table 124. Elanco Oral Bordetella Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Elanco Oral Bordetella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Elanco Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Oral Bordetella Vaccine Distributors List
Table 130. Oral Bordetella Vaccine Customers List
Table 131. Oral Bordetella Vaccine Market Trends
Table 132. Oral Bordetella Vaccine Market Drivers
Table 133. Oral Bordetella Vaccine Market Challenges
Table 134. Oral Bordetella Vaccine Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Bordetella Vaccine Product Picture
Figure 2. Global Oral Bordetella Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Oral Bordetella Vaccine Market Share by Type in 2022 & 2029
Figure 4. Combination Vaccine Product Picture
Figure 5. Only Bordetella Vaccine Product Picture
Figure 6. Global Oral Bordetella Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Oral Bordetella Vaccine Market Share by Application in 2022 & 2029
Figure 8. Puppies
Figure 9. Adult Dogs
Figure 10. Oral Bordetella Vaccine Report Years Considered
Figure 11. Global Oral Bordetella Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Oral Bordetella Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Oral Bordetella Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Oral Bordetella Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Oral Bordetella Vaccine Sales 2018-2029 ((K Units)
Figure 16. Global Oral Bordetella Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Oral Bordetella Vaccine Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Oral Bordetella Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Oral Bordetella Vaccine Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Oral Bordetella Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Oral Bordetella Vaccine Sales YoY (2018-2029) & (K Units)
Figure 22. China Oral Bordetella Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Oral Bordetella Vaccine Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Oral Bordetella Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Oral Bordetella Vaccine Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Oral Bordetella Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Oral Bordetella Vaccine in the World: Market Share by Oral Bordetella Vaccine Revenue in 2022
Figure 29. Global Oral Bordetella Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Oral Bordetella Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Oral Bordetella Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Oral Bordetella Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Oral Bordetella Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Oral Bordetella Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Oral Bordetella Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Oral Bordetella Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Oral Bordetella Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Oral Bordetella Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Oral Bordetella Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Oral Bordetella Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Oral Bordetella Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Oral Bordetella Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Oral Bordetella Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Oral Bordetella Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Oral Bordetella Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Oral Bordetella Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Oral Bordetella Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Oral Bordetella Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Oral Bordetella Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Oral Bordetella Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Oral Bordetella Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Oral Bordetella Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Oral Bordetella Vaccine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Oral Bordetella Vaccine Revenue Share by Region (2018-2029)
Figure 62. Asia Oral Bordetella Vaccine Sales Share by Region (2018-2029)
Figure 63. Japan Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. India Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Oral Bordetella Vaccine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Oral Bordetella Vaccine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Oral Bordetella Vaccine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Oral Bordetella Vaccine Sales Share by Country (2018-2029)
Figure 74. Brazil Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Oral Bordetella Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Oral Bordetella Vaccine Value Chain
Figure 80. Oral Bordetella Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries